Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology-Reference-Cited by-同舟云学术

Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

Published:2016-03-20 Issue:9 Volume:34 Page:987-1011
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Dizon Don S.¹,Krilov Lada¹,Cohen Ezra¹,Gangadhar Tara¹,Ganz Patricia A.¹,Hensing Thomas A.¹,Hunger Stephen¹,Krishnamurthi Smitha S.¹,Lassman Andrew B.¹,Markham Merry Jennifer¹,Mayer Erica¹,Neuss Michael¹,Pal Sumanta Kumar¹,Richardson Lisa C.¹,Schilsky Richard¹,Schwartz Gary K.¹,Spriggs David R.¹,Villalona-Calero Miguel Angel¹,Villani Gina¹,Masters Gregory¹

Affiliation:

1. Don S. Dizon, Massachusetts General Hospital, Boston; Erica Mayer, Dana-Farber Cancer Institute, Boston, MA; Lada Krilov and Richard Schilsky, American Society of Clinical Oncology, Alexandria, VA; Ezra Cohen, University of California San Diego, San Diego; Patricia A. Ganz, University of California Los Angeles, Los Angeles; Sumanta Kumar Pal, City of Hope Comprehensive Cancer Center, Duarte, CA; Tara Gangadhar, University of Pennsylvania; Stephen Hunger, Children's Hospital Center of Philadelphia,...

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2015.65.8427

Reference51 articles.

1. Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States

2. Invasive Cancer Incidence and Survival — United States, 2012

3. Pembrolizumab versus Ipilimumab in Advanced Melanoma

4. Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial

5. Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time;JAMA Oncology;2024-05-01

2. Disparities in clinical trial enrollment at a Canadian comprehensive cancer center: A 15‐year retrospective study;Cancer;2024-04-25

3. Nonlinear relationship between viral load and TCT in single/multiple HPV52 infection;Virology Journal;2024-04-23

4. Hydralazine loaded nanodroplets combined with ultrasound-targeted microbubble destruction to induce pyroptosis for tumor treatment;Journal of Nanobiotechnology;2024-04-20

5. Gefitinib Induces Apoptosis in NSCLC Cells by Promoting Glutaminolysis and Inhibiting the MEK/ERK Signaling Pathway;Discovery Medicine;2024